Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0192623309335060v1
37/4/395    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Savolainen, S. M.
Right arrow Articles by Elmore, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savolainen, S. M.
Right arrow Articles by Elmore, S. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Invited Review

Histology Atlas of the Developing Mouse Heart with Emphasis on E11.5 to E18.5

Saija M. Savolainen
Julie F. Foley
Susan A. Elmore

NIEHS, Cellular and Molecular Pathology Branch, Research Triangle Park, North Carolina, USA

Correspondence: Susan Elmore, NIEHS, P.O. Box 12233, Research Triangle Park, NC 27709, USA; e-mail:elmore{at}niehs.nih.gov. Address additional CD requests to: Beth Mahler:mahler1{at}niehs.nih.gov.

In humans, congenital heart diseases are common. Since the rapid progression of transgenic technologies, the mouse has become the major animal model of defective cardiovascular development. Moreover, genetically modified mice frequently die in utero, commonly due to abnormal cardiovascular development. A variety of publications address specific developmental stages or structures of the mouse heart, but a single reference reviewing and describing the anatomy and histology of cardiac developmental events, stage by stage, has not been available. The aim of this color atlas, which demonstrates embryonic/fetal heart development, is to provide a tool for pathologists and biomedical scientists to use for detailed histological evaluation of hematoxylin and eosin (H&E)-stained sections of the developing mouse heart with emphasis on embryonic days (E) 11.5–18.5. The selected images illustrate the main structures and developmental events at each stage and serve as reference material for the confirmation of the chronological age of the embryo/early fetus and assist in the identification of any abnormalities. An extensive review of the literature covering cardiac development pre-E11.5 is summarized in the introduction. Although the focus of this atlas is on the descriptive anatomic and histological development of the normal mouse heart from E11.5 to E18.5, potential embryonic cardiac lesions are discussed with a list of the most common transgenic pre- and perinatal heart defects. Representative images of hearts at E11.5–15.5 and E18.5 are provided in Figures 2–4, 6, 8, and 9. A complete set of labeled images (Figures E11.5–18.5) is available on the CD enclosed in this issue of Toxicologic Pathology. All digital images can be viewed online at https://niehsimages.epl-inc.com with the username "ToxPath" and the password "embryohearts."

Key Words: heart • embryo • mouse • in utero lethality

Abbreviations: AA, aortic arch arteries; • AAo, ascending aorta; • Ao, aortic trunk; • AoS, aortic sinuses; • AR, aortic root (vestibule); • ARL, accessory lobe of right lung; • AS, aortic sac; • ASD, atrial septal defect; • AVC, atrioventricular canal; • AVL, aortic valve leaflet; • AVS, atrioventricular septum; • AVSD, atrioventricular septal defect; • BC, bulbus cordis; • BVC, bulboventricular canal; • BVG, bulboventricular groove; • CAC, common atrial chamber; • CAP, mesenchymal cap of the SP; • CAVC, complete AV canal; • CL, compact layer; • COS, conal septum; • CT, cushion tissue; • DA, ductus arteriosus; • Dao, descending aorta; • DILV, double inlet left ventricle; • DoA, dorsal aorta; • DORV, double outlet right ventricle; • DPC, days post-conception; • E, esophagus; • E7.5–18.5, embryonic day 7.5–18.5; • ECCD, endocardial cushion defect; • H&E, hematoxylin and eosin; • IAC, inferior atrioventricular cushion; • IVC, inferior vena cava; • IVS, interventricular septum; • LA, left atrium; • LACV, left anterior cardinal vein; • LAVC, left atrioventricular canal; • LCCV, left common cardinal vein; • LLAC, left lateral atrioventricular cushion; • LSV, left superior vena cava; • LV, left ventricle; • MB, main bronchus; • MVL, mitral valve leaflet; • OCT, outflow tract cushion tissue; • OFT, outflow tract; • OP, ostium primum; • OS, ostium secundum; • PA, pulmonary artery; • PAA, pharyngeal arch artery; • PBS, phosphate buffered saline; • PC, pericardium; • PCC, pericardial cavity; • PLV, primitive (left) ventricle; • PM, papillary muscle; • PR, pulmonary root (infundibulum); • PRV, primitive right ventricle; • PT, pulmonary trunk; • PTA, persistent truncus arteriosus; • PVe, pulmonary vein; • PVL, pulmonary valve leaflet; • RA, right atrium; • RACV, right anterior cardinal vein; • RAVC, right atrioventricular canal; • RCCV, right common cardinal vein; • RLAC, right lateral atrioventricular cushion; • RPA, right pulmonary artery; • RSV, right superior vena cava; • RV, right ventricle; • SAC, superior atrioventricular cushion tissue; • SL, spongy layer; • SP, septum primum; • SS, septum secundum; • SSp, septum spurium; • SV, sinus venosus; • T, trachea; • TGA, transposition of great arteries; • Th, left and right thymic primordial; • TS, Theiler stage; • TSL, tricuspid septal leaflet; • TVL, tricuspid valve leaflet; • VS, vestibular spine; • VSD, ventricular septal defect; • VV, venous valve; • WAVC, wall of atrioventricular canal.

This version was published on June 1, 2009

Toxicologic Pathology, Vol. 37, No. 4, 395-414 (2009)
DOI: 10.1177/0192623309335060


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
B. A. de Boer, J. M. Ruijter, F. P. J. M. Voorbraak, and A. F. M. Moorman
More than a decade of developmental gene expression atlases: where are we now?
Nucleic Acids Res., December 1, 2009; 37(22): 7349 - 7359.
[Abstract] [Full Text] [PDF]